Analyst Research Report Snapshot

Title:

Ellex Medical Lasers Limited

Price:

$50.00

Provider:

MarketLine (a Datamonitor Company)

Date:

12 Aug 2013

Pages:

25

Type:

AcrobatPDF

Companies referenced:

ELX.AX

Available for Immediate Download
Summary:

Ellex Medical Lasers Limited - Company Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, product and service offerings, and corporate actions, providing a 360° view of the company. Features: - Detailed information on Ellex Medical Lasers Limited required for business and competitor intelligence needs - Intelligence on Ellex Medical Lasers Limited’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about Ellex Medical Lasers Limited, such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: Ellex Medical Lasers (Ellex) is engaged in designing, manufacturing and marketing of line of lasers and diagnostic ultrasound systems used by ophthalmologists to diagnose and treat eye disease. It offers photodisruptors to treat secondary cataracts; photocoagulators for treatment of age related macular degeneration and diabetic retinal diseases; SLT (selective laser trabeculoplasty) photoregeneration to treat glaucoma; and ultrasound imaging devices to visualize anatomy and structures below the surface of the retina. The company sells its products through distribution partners. It operates in Australia, the US, France, Germany, Japan and Asia. It is headquartered in Adelaide, Australia, and employs around 184 people. The company recorded revenues of A$47.5 million (approximately $49.1 million) in the fiscal year ended June 2012, an increase of 10.1% over 2011. The company's operating profit was A$1.5 million (approximately $1.5 million) in fiscal 2012, as compared to an operating loss of A$0.7 million (approximately $0.7 million) in 2011. Its net profit was A$1.1 million (approximately $1.1 million) in fiscal 2012, as compared to the net loss of A$0.7 million (approximately $0.7 million) in 2011. Reasons to Purchase: - Gain understanding of Ellex Medical Lasers Limited the company and its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess Ellex Medical Lasers Limited as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on Ellex Medical Lasers Limited your competitors' business structure, strategy and prospects

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.